Gas-phase behaviour of Ru(II) cyclopentadienyl-derived complexes with N-coordinated ligands by electrospray ionization mass spectrometry: fragmentation pathways and energetics

Bond fission in monocationic frameworks: diverse fragmentation pathways for phosphinophosphonium cations

A series of phosphinophosphonium cations ([R2PPMe3]+; R = Me, Et, i Pr, t Bu, Cy, Ph and N i Pr2) have been prepared and examined by collision-induced dissociation (CID) to determine the fragmentation pathways accessible to these prototypical catena-phosphorus cations in the gas-phase. Experimental evidence for fission of P-P and P-E (E = P, C) bonds, and β-hydride elimination has been obtained. Comparison of appearance potentials for the P-P bond dissociation fragments [R2P]+ (P-P heterolysis) and [PMe3]+˙ (P-P homolysis) shows that heterolytic P-P cleavage is more sensitive than P-P homolysis towards changes in substitution at the trivalent phosphorus center. The facility of β-hydride elimination increases with the steric bulk of R in [R2PPMe3]+. A density functional theory (DFT) study modelling these observed processes in gas-phase, counterion- and solvent-free conditions, to mimic the mass spectrometric environment, was performed for derivatives of [R2PPMe3]+ (R = Me, Et, i Pr, t Bu, Ph and N i Pr2), showing good agreement with experimental trends. The unusual observation of both homolytic and heterolytic cleavage pathways for the P-P and P-C bonds reveals new insight into the fundamental aspects of bonding in monocations and undermines the use of simplistic bonding models.

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds

Research on the field of metal complexes for the treatment of cancer diseases has attracted increasing interest due to the urgency in finding more efficient and selective treatments. Owing to their wide structural diversity, organometallic complexes appear as potential alternatives to the design of new anticancer candidates. Herein, we review recent progress in our work toward the development of new drugs based on Ru(II)- and Fe(II)-cyclopentadienyl scaffolds. Their design and chemical properties are reviewed and correlated with their biological effects, in particular the key role that coligands play in the overall behavior of the complex.

Rapid differentiation of ortho-, meta-, and para-isomers of halogenated phenylmethylidene hydrazinecarbodithioates by metal complexation and electrospray ionization mass spectrometry

RATIONALE

Development of mass spectrometry (MS)-based methods for isomeric differentiation remains a challenging analytical task, and has attracted the interest of many research groups. It is relevant to develop a general method to differentiate the isomeric halogenated phenylmethylidene hydrazinecarbodithioates (MX, X  =  F, Cl, Br).

METHODS

Diluted CH3 CN solutions containing NiCl2 and a title isomer (MX) were analyzed by electrospray ionization tandem mass spectrometry (ESI-MS(n)) in a quadrupole ion trap instrument equipped with an ESI source. Theoretical calculations were performed using the density functional theory (DFT) method at the uB3LYP/6-31+G(2d,p) level.

RESULTS

In MS(3) experiments, the complex [MX + SCH3 + Ni](+) ion, resulting from dissociation of the ESI-generated complex [2MX - H + Ni](+) ion, undergoes ligand-exchange reactions with residual gas molecules, such as water, acetonitrile, and nitrogen in the ion trap, and the o-isomers [Mo-X + SCH3 + Ni](+) were found to undergo the characteristic HX elimination reactions to afford several unique ions. Each set of three isomers [MX + SCH3 + Ni](+) show significantly different reactivity, which has been corroborated by MS(4) experiments and theoretical calculations.

CONCLUSIONS

A rapid method based on metal complexation and tandem mass spectrometric (MS(n)) analysis has been developed to differentiate three sets of positional isomers of halogenated phenylmethylidene hydrazinecarbodithioates (MX, X =  F, Cl, Br).